Antiarrhythmics: Difference between revisions

No edit summary
(Text replacement - "beta blocker" to "β-blocker")
 
(23 intermediate revisions by 5 users not shown)
Line 1: Line 1:
*[[Lidocaine]]
==Table==
*[[Procainamide]]
*[[Esmolol]]
*[[Labetalol]]
*[[Sotalol]]
*[[Amiodarone]]
*[[Ibutilide]]
*[[Diltiazem]]
*[[Atropine]]
*[[Adenosine]]
*[[Digoxin]]
*[[Isoproterenol]]
*[[Magnesium]]
 
 
=== Overview table  ===


{| class="wikitable"
{| class="wikitable" style="width: 641px; height: 711px;"
|-
|-
! Class  
! Class  
Line 28: Line 13:
|  
|  
*Quinidine  
*Quinidine  
*[[Procainamide]]
*[[Procainamide]]  
*Disopyramide
*Disopyramide


Line 41: Line 26:
|  
|  
|  
|  
*[[Lidocaine]]
*[[Lidocaine]]  
*Phenytoin  
*Phenytoin  
*Mexiletine  
*Mexiletine  
Line 50: Line 35:
*treatment and prevention during and immediately after Myocardial infarction, though this practice is now discouraged given the increased risk of Asystole  
*treatment and prevention during and immediately after Myocardial infarction, though this practice is now discouraged given the increased risk of Asystole  
*Ventricular tachycardia  
*Ventricular tachycardia  
*[[Atrial_Fibrillation_(Main)|Atrial fibrillation]]
*[[Atrial Fibrillation (Main)|Atrial fibrillation]]


|-
|-
Line 56: Line 41:
|  
|  
|  
|  
*Flecainide  
*[[Flecainide]]
*Propafenone  
*Propafenone  
*Moricizine
*Moricizine
Line 68: Line 53:
|-
|-
! II  
! II  
| Beta-blockers  
| [[Beta-blockers]]
|  
|  
*Propranolol  
*Propranolol  
*[[Esmolol]]
*[[Esmolol]]  
*Timolol  
*Timolol  
*Metoprolol  
*[[Metoprolol]]
*Atenolol  
*[[Atenolol]]
*Bisoprolol
*Bisoprolol  
*[[Labetalol]]
*[[Labetalol]]


Line 87: Line 72:
|  
|  
|  
|  
*[[Amiodarone]]
*[[Amiodarone]]  
*[[Sotalol]]
*[[Sotalol]]  
*[[Ibutilide]]
*[[Ibutilide]]  
*Dofetilide  
*Dofetilide  
*Dronedarone  
*Dronedarone  
Line 97: Line 82:
K<sup>+</sup> channel blocker  
K<sup>+</sup> channel blocker  


Sotalol is also a beta blocker  
Sotalol is also a β-blocker  


Amiodarone has Class I, II, and III activity  
Amiodarone has Class I, II, and III activity  
Line 104: Line 89:
*In [[Wolf Parkinson White (WPW)]]  
*In [[Wolf Parkinson White (WPW)]]  
*(sotalol:) Ventricular tachycardias and Atrial fibrillation  
*(sotalol:) Ventricular tachycardias and Atrial fibrillation  
*(Ibutilide:) Atrial flutter and [[Atrial_Fibrillation_(Main)|Atrial fibrillation]]
*(Ibutilide:) Atrial flutter and [[Atrial Fibrillation (Main)|Atrial fibrillation]]


|-
|-
Line 116: Line 101:
|  
|  
*prevent recurrence of Paroxysmal supraventricular tachycardia  
*prevent recurrence of Paroxysmal supraventricular tachycardia  
*reduce Ventricular rate in patients with [[Atrial_Fibrillation_(Main)|Atrial fibrillation]]
*reduce Ventricular rate in patients with [[Atrial Fibrillation (Main)|Atrial fibrillation]]


|-
|-
Line 122: Line 107:
|  
|  
|  
|  
*[[Adenosine]]
*[[Adenosine]]  
*[[Digoxin]]
*[[Digoxin]]  
*[[Magnesium]] Sulfate
*[[Magnesium sulfate]]


| Work by other or unknown mechanisms (Direct nodal inhibition).  
| Work by other or unknown mechanisms (Direct nodal inhibition).  
Line 130: Line 115:
Used in supraventricular arrhythmias,  
Used in supraventricular arrhythmias,  


Or in the case of Magnesium Sulfate, used in Torsade de Pointe.
Or in the case of [[magnesium sulfate]], used in [[torsade de pointes]].  


|}
|}


==See Also==
*[[Arrhythmias (DDX)]]
*[[Atropine]]
*[[Isoproterenol]]


== For Bradyarrythmias: ==
==References==
 
<references/>
*[[Atropine]]
*[[Isoproterenol]]
*Katzung &amp; Trevor's Pharmacology


=== Source ===
[[Category:Pharmacology]] [[Category:Cardiology]]
Tintinalli
Katzung & Trevor's Pharmacology
[[Category:Drugs]]  
[[Category:Cards]]

Latest revision as of 18:13, 14 August 2017

Table

Class Known as Examples Mechanism Clinical uses
Ia fast-channel blockers-Affect QRS complex (Na+) channel block (intermediate association/dissociation)
  • Ventricular arrhythmias
  • prevention of paroxysmal Recurrent atrial fibrillation (triggered by Vagus nerve overactivity)
  • procainamide in Wolf Parkinson White (WPW)
Ib- Do not affect QRS complex (Na+) channel block (fast association/dissociation)
  • treatment and prevention during and immediately after Myocardial infarction, though this practice is now discouraged given the increased risk of Asystole
  • Ventricular tachycardia
  • Atrial fibrillation
Ic (Na+) channel block (slow association/dissociation)
  • prevents Paroxysmal atrial fibrillation
  • treats Recurrent tachyarrhythmias of abnormal conduction system.
  • contraindicated immediately post-myocardial infarction.
II Beta-blockers beta blocking
Propranolol also shows some class I action
  • decrease Myocardial infarction mortality
  • prevent recurrence of Tachyarrhythmias
III

K+ channel blocker

Sotalol is also a β-blocker

Amiodarone has Class I, II, and III activity

IV slow-channel blockers Ca2+ channel blocker
  • prevent recurrence of Paroxysmal supraventricular tachycardia
  • reduce Ventricular rate in patients with Atrial fibrillation
V Work by other or unknown mechanisms (Direct nodal inhibition).

Used in supraventricular arrhythmias,

Or in the case of magnesium sulfate, used in torsade de pointes.

See Also

References


  • Katzung & Trevor's Pharmacology